By Birth & Baby University · Last updated: October 2026 · 8 min read
Spit-up is one of the most visible features of early infancy. Parents describe babies who spit after every feed, arch their backs, fuss and refuse the bottle, and they wonder whether this is “reflux” or “GERD” and whether medication is needed. Postpartum doulas see this daily, along with the temptation to prop babies up to sleep or to suggest remedies. The distinction between ordinary reflux and gastroesophageal reflux disease matters because the evidence about treatment has shifted: acid-suppressing medicines, widely prescribed to infants, did not outperform placebo in the best-known trial. This article explains what pediatric sources describe as normal, which signs point to a problem, what trials show and where a doula’s role stops.
Key takeaways
Quick answer: reflux (GER) is normal in infants, typically begins at 2 to 3 weeks, peaks at 4 to 5 months and mostly resolves by 9 to 12 months. It becomes a disease (GERD) when it comes with complications such as poor weight gain, refusal to feed or respiratory symptoms. First-line management is feeding and position adjustments, and a randomized trial found a proton pump inhibitor no better than placebo for symptoms attributed to GERD in infants. Babies with reflux should still sleep flat on their backs.
- The AAP says GER is considered normal in infants, “happy spitters” are not cranky or in much pain, and lifestyle changes (feeding and/or position changes) are recommended as first-line therapy for both GER and GERD.
- A multicenter randomized, placebo-controlled trial of 162 infants aged 1 to 12 months found 54% responders in both the lansoprazole and placebo groups, and serious adverse events, particularly lower respiratory tract infections, occurred more often with lansoprazole (10 versus 2).
- The AAP’s safe sleep guidance says even babies with GERD should sleep flat on their backs.
- The 2018 joint NASPGHAN and ESPGHAN guideline update formulated recommendations and two algorithms, one for infants under 12 months, based on a systematic search with GRADE assessment and expert opinion where trials were lacking.

What the research says
What is normal. The AAP’s page on GER and GERD (last updated December 2024) defines reflux as the movement of stomach contents into the esophagus and sometimes out through the mouth and nose. It says GER usually begins at about 2 to 3 weeks of age and peaks between 4 and 5 months, and that for most full-term babies symptoms go away by 9 to 12 months as the digestive tract matures, with improved head control, sitting and the introduction of solid food helping. “Happy spitters” are not cranky and do not appear to be in much pain. The page says that when reflux is associated with other symptoms or lasts beyond infancy it is considered GERD.
When to be concerned. The AAP lists signs for which parents should contact the pediatrician: refusal to feed; crying or arching the back during feeds as if in pain; blood or a greenish color in the spit-up; increased frequency or intensity of spit-up, for example forceful; a swollen, distended or hard belly; and respiratory symptoms such as wheezing and coughing. It adds that a baby who is not gaining weight or has fewer wet and BM diapers may not be keeping enough food down. It says the pediatrician will review symptoms and feeding patterns and plot growth on a growth chart, and that referral to a pediatric gastroenterologist may follow for poor weight gain or feeding problems. These are the points where observation by a doula should become a referral. The AAP also notes that milk allergy can cause symptoms similar to GER or GERD, so the pediatrician may suggest a trial of a dairy-free diet for a breastfeeding parent or a special formula, a decision for the clinician.
What to try first. The AAP lists burping at natural pauses in an upright position, keeping the baby upright for about the first half hour after a feed with close supervision, considering smaller and more frequent feeds while making sure the baby gets enough, and, if a bottle-fed baby spits up unusually often, the possibility that the pediatrician recommends thickening formula with a small amount of baby cereal. It cautions never to add solids to the bottle unless the pediatrician advises it. The 2018 NASPGHAN and ESPGHAN joint guideline (Rosen and colleagues) updated the 2009 recommendations on diagnosis and management of GERD in infants and children. It built its recommendations on a systematic literature search and GRADE, used expert opinion where no randomized trials or diagnostic accuracy studies were available, and produced separate algorithms for infants under 12 months and for older infants and children. This article draws on the abstract, not the recommendations themselves, so it does not summarize the guideline’s specific advice.
Do acid-suppressing medicines help? In Orenstein and colleagues’ 2009 trial, 162 infants aged 1 to 12 months with symptoms attributed to GERD that had persisted despite at least one week of nonpharmacologic management were randomized to lansoprazole or placebo for 4 weeks. The primary outcome was a 50% or greater reduction in feeding-related crying. Responders were 54% in both groups (44 of 81 each). No significant differences were detected on secondary measures. Treatment-emergent adverse events occurred in 62% of lansoprazole recipients and 46% of placebo recipients (p = 0.058), and serious adverse events, particularly lower respiratory tract infections, occurred in 12 infants, significantly more often in the lansoprazole group (10 versus 2; p = 0.032). The authors concluded there was no difference in efficacy between lansoprazole and placebo for symptoms attributed to GERD in infants 1 to 12 months old. A more recent analysis of spontaneous adverse event reports to the US FDA by Tezel Yalçın and colleagues (2025) covered 464 neonates and infants receiving a single proton pump inhibitor, of which 69.6% of reports were described as serious and vomiting was the most reported event. Such reports cannot show how often problems occur, since they lack a denominator and a comparison group, but they add to the caution about routine use. The authors also note that only esomeprazole is FDA-approved for infants under one year.

What this means for doulas
- Reassure within the evidence. “Spit-up is common and usually improves by 9 to 12 months, as long as the baby is feeding, gaining and comfortable” matches the AAP. Do not say “it’s nothing” without checking those conditions.
- Know the referral signs. Poor weight gain, fewer diapers, refusal to feed, back arching with pain, blood, green spit-up, forceful vomiting, wheezing or coughing, and a hard belly go to the pediatric provider. The AAP page lists blood or a greenish color in the spit-up among the signs that should prompt contact with the pediatrician.
- Offer low-risk feeding measures. Burping at pauses, calm feeds and holding upright after feeding under supervision are on the AAP’s list. Do not give solids or thickeners unless the pediatrician says so.
- Do not recommend medication, thickened feeds or elevated sleep. The AAP says even babies with GERD should sleep flat on their backs. The AAP says any surface inclined more than 10 degrees is not safe for sleep, so a wedge or incline is not an answer (see Safe Sleep Recommendations: What Every Postpartum Doula Must Know).
- Be careful about labels. A fussy baby with spit-up is not necessarily a baby with reflux disease. See Colic and Excessive Crying: What Research Says About Causes and Interventions.
Putting the evidence into practice
- Take a history. How much spit-up, how often, how forceful, what color, how the baby feeds, weight at the last check, diapers.
- Apply the checklist. If any referral sign is present, encourage same-day contact with the pediatric provider.
- Adjust feeding gently. Burp mid-feed, pace the bottle, avoid overfeeding, and hold the baby upright after feeds while watching them, as the AAP describes.
- Keep sleep safe. Flat on the back in a firm, noninclined sleep space. If the baby spits up on their back, that alone is not a reason to change position, and the AAP says babies will not choke on their backs.
- Support the parents. Laundry, patience and reassurance matter. Record episodes if the pediatrician asks for it.
Limits and uncertainty
The trial summarized here tested one medicine in infants with symptoms attributed to GERD after a trial of nonpharmacologic care, so it does not cover all medicines or all infants, such as those with proven erosive disease. The adverse event database analysis cannot establish rates. This article draws on the AAP pages in full and the abstracts of the guideline, the trial and the reports, not the recommendations of the guideline. Practice guidelines and product approvals change, and premature infants and babies with other medical conditions need individualized plans from their clinicians. This article is not a guide to diagnosis or treatment.
The bottom line
Most infant reflux is normal, harmless and temporary. When it comes with poor weight gain, pain, feeding refusal or breathing symptoms it needs a clinician, and the best-known trial found a common acid-suppressing medicine no better than placebo for infant symptoms, with more serious infections in the treated group. A doula can reassure accurately, support gentle feeding measures, insist on flat back sleeping and recognize the signs that mean a call to the pediatrician.
Birth & Baby University’s For Doulas page brings together its postpartum doula training, recertification and mentorship for doulas who support families through feeding and early infant care. Confirm that any program meets your certifier’s, employer’s or state’s requirements before you enroll.
This article is for professional education. It is not medical, legal or tax advice. Check the standards of your certifying organization and the rules where you work. For concerns about a baby’s health, contact a pediatric provider or emergency services.
Sources and further reading
- American Academy of Pediatrics. Gastroesophageal Reflux (GER) & Gastroesophageal Reflux Disease (GERD) (HealthyChildren.org, last updated December 2024). Read the source
- Rosen R, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of NASPGHAN and ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition (2018). Read the source
- Orenstein SR, et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. Journal of Pediatrics (2009). Read the source
- Tezel Yalçın H, et al. Real-world safety profile of proton pump inhibitors in infants as reported in the FDA Adverse Event Reporting System (FAERS). Pharmaceuticals (2025). Read the source
- American Academy of Pediatrics. How to Keep Your Sleeping Baby Safe: AAP Policy Explained (HealthyChildren.org, updated September 2026). Read the source
More for professionals: the Professionals Blog.
Leave a Reply